Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

Rituxan Treats Rheumatoid Arthritis

Study Shows Low Doses of Rituxan as Effective as Higher Doses

Testing Rituxan continued...

The study is published in the May issue of the journal Arthritis and Rheumatism. It was funded by drug makers Genentech, Biogen, and Hoffmann-La Roche, which market the drug jointly. Genentech and Biogen are WebMD sponsors.

There were nine different treatment groups, designed to better understand which doses of drugs were most effective and whether adding steroids improved outcomes.

A total of 55% of the patients treated with the higher-dose Rituxan regimen showed a 20% or better improvement after six months, compared with 54% of patients on the low-dose regimen and 28% of patients taking a placebo.

Steroids, whether given in the vein or by mouth, didn't add any further improvement than Rituxan and methotrexate alone. But intravenous steroids given prior to Rituxan made the drug more tolerable.

Lower Doses, Fewer Steroids?

These finding suggest that high doses of steroids, which have many side effects when used long term, may not be needed in these patients.

Rheumatologist Simon Helfgott, MD, tells WebMD that this comes as no surprise. Helfgott treats rheumatoid arthritis patients at Brigham and Women's Hospital in Boston; he says about 40% of his patients are on biologics.

"Those of us who have been using this drug and following this understand that you don't need to give the whopping doses of steroids that were used in the early trials," he says.

He says Rituxan is emerging as a useful therapy for patients who fail treatment with the tumor necrosis factor (TNF)-targeting biologics, such as Enbrel, Humira and Remicade.

"The difference in its mode of action is intriguing," he says. "Some patients strike out on all of the anti-TNF agents. It will be interesting to see how they respond to this drug."

1 | 2

Today on WebMD

rubbing hands
Avoid these 6 common mistakes.
mature couple exercising
Decrease pain, increase energy.
mature woman threading needle
How much do you know?
Swelling, fatigue, pain, and more.
Lucille Ball
Hand bones X-ray
prescription pills
Woman massaging her neck
woman roasting vegetables in oven
Woman rubbing shoulder
Working out with light weights